EUVIMEDEUVIMED entdecken
Crossref

Relationship Between Corticosteroid Administration and Survival Period in Terminal Cancer Patients

Hideki Katayama iD, Masahiro Tabata, Haruhito Kamei, Yusuke Mimura, Yoshinobu Maeda

Journal of Palliative Care · 2024

DOI: 10.1177/08258597231221924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Palliative Care, 2024. Verfasst von Hideki Katayama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative and Supportive Care, Okayama University Hospital, Okayama city, Japan. Hauptthemen laut MEDLINE: Neoplasms, Adrenal Cortex Hormones, Palliative Care, Terminal Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Corticosteroids are commonly used for symptom relief in patients with terminal cancer, but their use may have an impact on patient survival. We compared the survival of patients with terminal cancer who did and did not receive corticosteroid treatment for symptom relief, stratified by their predicted prognosis.

Methods

We retrospectively reviewed consecutive patients with cancer who received corticosteroid treatment for symptom relief in a single palliative care unit. We stratified the patients according to their predicted prognosis using the palliative prognostic (PaP) score either before starting the corticosteroid treatment or at admission for control patients who did not receive a corticosteroid treatment. The 2 groups were compared for survival based on the PaP Scores.

Results

We analyzed 204 patients treated with a corticosteroid during the study period and 139 control patients who did not receive corticosteroids during their treatment. No difference was observed in the survival between the treatment and control groups.

Conclusion

Corticosteroid treatment for symptom relief in patients with terminal cancer did not affect survival time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAdrenal Cortex HormonesPalliative CareTerminal CareHumansMaleFemaleRetrospective StudiesAgedMiddle AgedAged, 80 and overPrognosisSurvival AnalysisAdult

Stichwörter der Autor:innen

corticosteroidsprognosissurvivalsymptom reliefterminal cancer

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Palliative and Supportive Care, Okayama University Hospital, Okayama city, Japan.
  • Clinical Cancer Center, Okayama University Hospital, Okayama city, Japan.
  • National Hospital Organization Yamaguchi-Ube Medical Center, Ube city, Japan.
  • Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama city, Japan.

ORCID-Profile: Hideki Katayama

Zitieren

APA

Katayama, H., Tabata, M., Kamei, H., Mimura, Y., & Maeda, Y. (2024). Relationship Between Corticosteroid Administration and Survival Period in Terminal Cancer Patients. Journal of Palliative Care. https://doi.org/10.1177/08258597231221924

Vancouver

Katayama H, Tabata M, Kamei H, Mimura Y, Maeda Y. Relationship Between Corticosteroid Administration and Survival Period in Terminal Cancer Patients. Journal of Palliative Care. 2024. doi:10.1177/08258597231221924

BibTeX
@article{Katayama2024,
  author = {Katayama, Hideki and Tabata, Masahiro and Kamei, Haruhito and Mimura, Yusuke and Maeda, Yoshinobu},
  title = {Relationship Between Corticosteroid Administration and Survival Period in Terminal Cancer Patients},
  journal = {Journal of Palliative Care},
  year = {2024},
  doi = {10.1177/08258597231221924}
}
Kostenlos starten →